Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$743M |
| 2 |
Medtronic
MDT
|
+$603M |
| 3 |
AbbVie
ABBV
|
+$384M |
| 4 |
Intel
INTC
|
+$336M |
| 5 |
KKR.PRC
KKR & Co. Inc. 6.00% Series C Mandatory Convertible Preferred Stock
KKR.PRC
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$917M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$732M |
| 3 |
iShares Russell 1000 ETF
IWB
|
+$640M |
| 4 |
Procter & Gamble
PG
|
+$423M |
| 5 |
Merck
MRK
|
+$414M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.01% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 9.84% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Kyndryl
KD
$2.66B
| $13.9M | 0.01% |
+765,587
| New | +$16.5M |
|
927
Acadia Healthcare
ACHC
$3.17B
| $13.7M | ﹤0.01% |
225,908
-1,853
| -0.8% | -$110K |
|
928
Kura Oncology
KURA
$922M
| $13.6M | ﹤0.01% |
974,922
-3,533
| -0.4% | -$57.2K |
|
|
EQRX
929
DELISTED
EQRx, Inc. Common Stock
EQRX
| $13.6M | ﹤0.01% |
2,000,000
| – | – |
|
930
Pulmonx
LUNG
$49.4M
| $13.4M | ﹤0.01% |
417,457
-1,833
| -0.4% | -$66.9K |
|
|
SCHR
931
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.2B
| $13.1M | ﹤0.01% |
467,772
-25,426
| -5% | -$716K |
|
932
Doximity
DOCS
$3.67B
| $13M | ﹤0.01% |
260,265
+54,690
| +27% | +$3.56M |
|
933
Corteva
CTVA
$59.7B
| $13M | ﹤0.01% |
275,386
-23,623
| -8% | -$1.08M |
|
934
Hims & Hers Health
HIMS
$6.5B
| $12.9M | ﹤0.01% |
1,971,747
-200
| -0% | -$1.45K |
|
|
CDMO
935
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $12.9M | ﹤0.01% |
+442,348
| New | +$12.7M |
|
936
Carrier Global
CARR
$57.2B
| $12.8M | ﹤0.01% |
236,855
-4,834
| -2% | -$261K |
|
937
Expeditors International
EXPD
$22.9B
| $12.8M | ﹤0.01% |
95,124
-14,218
| -13% | -$1.78M |
|
938
Arcutis Biotherapeutics
ARQT
$3.42B
| $12.8M | ﹤0.01% |
615,745
+40,537
| +7% | +$807K |
|
939
Braze
BRZE
$2.45B
| $12.8M | ﹤0.01% |
+165,353
| New | +$12M |
|
940
Snap-on
SNA
$20.9B
| $12.7M | ﹤0.01% |
59,141
-5,074
| -8% | -$1.08M |
|
941
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.22B
| $12.7M | ﹤0.01% |
91,624
+20,770
| +29% | +$2.83M |
|
942
Campbell Soup
CPB
$6.51B
| $12.7M | ﹤0.01% |
291,826
-5,048
| -2% | -$210K |
|
943
Packaging Corp of America
PKG
$22.7B
| $12.6M | ﹤0.01% |
92,228
-6,148
| -6% | -$827K |
|
944
Factset
FDS
$9.05B
| $12.5M | ﹤0.01% |
25,779
+5,516
| +27% | +$2.47M |
|
|
SRCL
945
DELISTED
Stericycle Inc
SRCL
| $12.5M | ﹤0.01% |
+208,814
| New | +$13.1M |
|
|
SAGE
946
DELISTED
Sage Therapeutics
SAGE
| $12.4M | ﹤0.01% |
291,580
+935
| +0.3% | +$39.1K |
|
947
Conagra Brands
CAG
$7.07B
| $12.4M | ﹤0.01% |
362,776
+203
| +0.1% | +$6.65K |
|
948
Synchrony
SYF
$23.7B
| $12.4M | ﹤0.01% |
267,029
+48,750
| +22% | +$2.34M |
|
949
Occidental Petroleum
OXY
$57B
| $12.4M | ﹤0.01% |
426,397
-35,796
| -8% | -$1.12M |
|
950
Molina Healthcare
MOH
$10.3B
| $12.3M | ﹤0.01% |
38,553
+3,826
| +11% | +$1.14M |
|
Similar funds
Franklin Resources's Q4 2021 Portfolio in Review
As of Q4 2021, Franklin Resources held 2,610 positions worth $277B, up 4.4% from $266B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Franklin Resources withdrew a net $8.82B in Q4 2021, closing 141 positions and reducing 1,108 holdings. Its most notable exit was Kansas City Southern, an estimated $282M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Franklin Resources opened a new position in Rivian worth $669M.
- Franklin Resources's largest Q4 2021 buy was Rivian: 6,451,069 shares worth $669M.
- Franklin Resources added most to Medtronic in Q4 2021, an estimated $603M increase.
- Franklin Resources's biggest Q4 2021 reduction was Vanguard Total Bond Market, cutting an estimated $917M.
- Franklin Resources fully exited Kansas City Southern in Q4 2021, selling an estimated $282M.
- Franklin Resources's ten largest holdings make up 14% of its $277B portfolio in Q4 2021.
- Franklin Resources opened 157 new positions and closed 141 in Q4 2021.
- Franklin Resources's portfolio value rose 4.4% quarter-over-quarter to $277B.
Based on Franklin Resources's 13F filing for Q4 2021, filed 11 Feb 2022.